PACB

PACB

USD

Pacific Biosciences of California Inc. Common Stock

$1.760+0.020 (1.149%)

Real-time Price

Healthcare
Medical devices
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.740

High

$1.790

Low

$1.630

Volume

10.33M

Company Fundamentals

Market Cap

531.4M

Industry

Medical devices

Country

United States

Trading Stats

Avg Volume

8.24M

Exchange

NMS

Currency

USD

52-Week Range

Low $0.85Current $1.760High $2.66

Related News

Analyst Upgrades

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences with a Overweight and raises the price target from $1.8 to $2.

View more
Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2
GlobeNewswire

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry

View more
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
GlobeNewswire

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,

View more
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025